3D-Printed brain surgery guide may stop dangerous blood clots from returning

NCT ID NCT07720687

First seen Jul 22, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

Chronic subdural hematoma is a blood collection on the brain's surface common in older adults. Standard drainage surgery works, but the clot can come back. This trial tests whether using a custom 3D-printed template to guide the surgery, plus sealing a nearby artery during the procedure, can lower the risk of recurrence. About 440 adults needing surgery will be randomly assigned to the new approach or standard care, and followed for three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a patient-specific 3D-printed surgical template combined with intraoperative coagulation of the middle meningeal artery
What this could lead to
If successful, this approach could lower the chance that a chronic subdural hematoma comes back after surgery, reducing the need for repeat procedures.
What could go wrong
This is a relatively early-stage trial, and the added procedure may not reduce recurrence or could carry extra risks like bleeding or damage to nearby structures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hematoma, Subdural, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230601, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.